TABLE 5.
Metabolism-based analysis of metabolic pathways involved in the metabolism of characteristic metabolites.
| No. | Pathway name | Match Status | Raw p | -log(p) | Impact | Details |
|---|---|---|---|---|---|---|
| 1 | Arginine and proline metabolism | 2/38 | 0.03477 | 1.4588 | 0.05278 | KEGG |
| 2 | Phenylalanine metabolism | 1/12 | 0.091683 | 1.0377 | 0.0 | KEGG |
| 3 | Butanoate metabolism | 1/15 | 0.11337 | 0.9455 | 0.03175 | KEGG |
| 4 | Alanine, aspartate and glutamate metabolism | 1/28 | 0.20195 | 0.6947 | 0.04808 | KEGG |
| 5 | Porphyrin and chlorophyll metabolism | 1/30 | 0.21484 | 0.6678 | 0.02799 | KEGG |
| 6 | Cysteine and methionine metabolism | 1/33 | 0.23381 | 0.6311 | 0.05271 | KEGG |
| 7 | Glycine, serine and threonine metabolism | 1/34 | 0.24004 | 0.6197 | 0.03523 | KEGG |
| 8 | Valine, leucine and isoleucine degradation | 1/40 | 0.27645 | 0.5583 | 0.02264 | KEGG |
| 9 | Tryptophan metabolism | 1/41 | 0.28236 | 0.5492 | 0.01391 | KEGG |
Total cmpd was the total number of compounds in the pathway; Hits was the actually matched number from the user uploaded data; the Raw p was the original p-value calculated from the enrichment analysis; the Holm p was the p-value adjusted by Holm-Bonferroni method; the FDR p, was the p-value adjusted using False Discovery Rate; the Impact was the pathway impact value calculated from pathway topology analysis.